Companies:
49,940
Total Market Cap:
142451357883719.73
CNS Pharmaceuticals
NASDAQ: CNSP
Healthcare
Biotechnology
Global Rank
#44565
Country Rank
#5495
Market Cap
4.01 M
Price
8.82
Change (%)
2.68%
Volume
42,616
CNS Pharmaceuticals's latest marketcap:
4.01 M
As of 07/26/2025, CNS Pharmaceuticals's market capitalization has reached $4.01 M. According to our data, CNS Pharmaceuticals is the 44565th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 4.01 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | -15,614,373 |
| Shares Out | 455,162 |
| EPS (ttm) | -176.26 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/13/2025 |
Market Cap Chart
Data Updated: 07/26/2025
CNS Pharmaceuticals's yearly market capitalization.
CNS Pharmaceuticals has seen its market value drop from $64.88 M to $4.01 M since 2019, representing a total decrease of 93.81% and an annual compound decline rate (CAGR) of 39.32%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 07/26/2025 | $4.01 M | -43.51% | 44565 |
| 12/31/2024 | $6.92 M | 4.4% | 39631 |
| 12/29/2023 | $6.63 M | 109.26% | 38715 |
| 12/30/2022 | $3.17 M | -83.83% | 39385 |
| 12/31/2021 | $19.6 M | -51.07% | 32843 |
| 12/31/2020 | $40.05 M | -38.27% | 25818 |
| 12/31/2019 | $64.88 M | n/a |
Company Profile
CNS Pharmaceuticals was founded in 2017 in United States.
The company went public on 11/08/2019
on the Nasdaq Stock Market.
With 5 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is CNS Pharmaceuticals's (CNSP) current market cap?As of 07/26/2025, CNS Pharmaceuticals (including the parent company, if applicable) has an estimated market capitalization of $4.01 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does CNS Pharmaceuticals (CNSP) rank globally by market cap?CNS Pharmaceuticals global market capitalization ranking is approximately 44565 as of 07/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.